TISSUE DISTRIBUTION AND CLEARANCE OF SOLUBLE MURINE TNF RECEPTORS IN MICE

被引:49
作者
BEMELMANS, MHA [1 ]
GOUMA, DJ [1 ]
BUURMAN, WA [1 ]
机构
[1] ACAD MED CTR,DEPT SURG,AMSTERDAM,NETHERLANDS
关键词
KIDNEY; STNFR; TNF;
D O I
10.1016/1043-4666(94)90048-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, clearance of sTNFR was investigated. The data show that bilateral nephrectomy results in an increase of the levels of both sTNFR after which a new steady state situation develops, suggesting that other organs, apart from the kidneys, are involved in clearing of sTNFR. Bilateral nephrectomy also leads to an increase in circulating TNF. This TNF was detected by ELISA and appeared to be not biologically active. To investigate whether the endotoxin induced increase in sTNFR is dependent of renal function, endotoxin was injected in nephrectomized mice. The data show that nephrectomy followed by endotoxin injection resulted in a further increase of the levels of both sTNFR. However, the endotoxin induced increase in nephrectomized mice was similar to the situation in normal mice after LPS indicating that the endotoxin induced increase is kidney independent in these mice. To investigate the relative participation of various organs in sTNFR clearance, I-125 labelled sTNFR-P75 was injected. The data reveal that the majority of the sTNFR is removed from the circulation by the kidneys although indications for involvement of the liver and the lungs were also obtained. Calculation of the parametric clearance revealed that nephrectomy resulted in a 50% reduction of sTNFR-P75 clearance. Furthermore, the data presented strongly suggest that sTNFR release seems to be a continuous process, which is in balance with clearance of the sTNFR by the kidney, although other organs such as the liver and the lungs are involved.
引用
收藏
页码:608 / 615
页数:8
相关论文
共 38 条
[1]  
ADERKA D, 1992, LYMPHOKINE CYTOK RES, V11, P157
[2]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[3]   PROTECTION AGAINST ENDOTOXIC-SHOCK BY A TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOADHESIN [J].
ASHKENAZI, A ;
MARSTERS, SA ;
CAPON, DJ ;
CHAMOW, SM ;
FIGARI, IS ;
PENNICA, D ;
GOEDDEL, DV ;
PALLADINO, MA ;
SMITH, DH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) :10535-10539
[4]  
BEMELMANS MHA, 1993, J IMMUNOL, V150, P2007
[5]  
BEMELMANS MHA, 1993, J IMMUNOL, V151, P5554
[6]  
BERTINI R, 1993, EUR CYTOKINE NETW, V4, P39
[7]   PLASMA TUMOR-NECROSIS-FACTOR SOLUBLE RECEPTORS IN CHRONIC-RENAL-FAILURE [J].
BROCKHAUS, M ;
BARKHAYIM, Y ;
GURWICZ, S ;
FRENSDORFF, A ;
HARAN, N .
KIDNEY INTERNATIONAL, 1992, 42 (03) :663-667
[8]  
DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L
[9]   ROLE OF TUMOR NECROSIS FACTOR IN THE ENHANCED SENSITIVITY OF MICE TO ENDOTOXIN AFTER EXPOSURE TO LEAD [J].
DENTENER, MA ;
GREVE, JW ;
MAESSEN, JG ;
BUURMAN, WA .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1989, 11 (2-3) :321-334
[10]  
DING AH, 1992, P SOC EXP BIOL MED, V200, P458